These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25512460)

  • 1. Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: the ALBI scoring model.
    Knox JJ
    J Clin Oncol; 2015 Feb; 33(6):529-31. PubMed ID: 25512460
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.
    Johnson PJ; Berhane S; Kagebayashi C; Satomura S; Teng M; Reeves HL; O'Beirne J; Fox R; Skowronska A; Palmer D; Yeo W; Mo F; Lai P; Iñarrairaegui M; Chan SL; Sangro B; Miksad R; Tada T; Kumada T; Toyoda H
    J Clin Oncol; 2015 Feb; 33(6):550-8. PubMed ID: 25512453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALBI grade as a new player in hepatocellular carcinoma.
    Huo TI
    J Chin Med Assoc; 2019 Jan; 82(1):1. PubMed ID: 30839395
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices.
    Chen PH; Hsieh WY; Su CW; Hou MC; Wang YP; Hsin IF; Yang TC; Liao WC; Lin HC; Lee FY; Wu JC
    Gastrointest Endosc; 2018 Aug; 88(2):230-239.e2. PubMed ID: 29317268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.
    Hickey R; Mouli S; Kulik L; Desai K; Thornburg B; Ganger D; Baker T; Abecassis M; Ralph Kallini J; Gabr A; Gates VL; Benson Iii AB; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2016 Jun; 27(6):795-802. PubMed ID: 27038686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
    J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Lo CH; Liu MY; Lee MS; Yang JF; Jen YM; Lin CS; Chao HL; Shen PC; Huang WY
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):145-152. PubMed ID: 28816140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
    Ogasawara S; Chiba T; Ooka Y; Suzuki E; Kanogawa N; Saito T; Motoyama T; Tawada A; Kanai F; Yokosuka O
    Invest New Drugs; 2015 Dec; 33(6):1257-62. PubMed ID: 26462681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.
    Gkika E; Bettinger D; Krafft L; Schultheiss M; Neeff HP; Maruschke L; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
    Strahlenther Onkol; 2018 May; 194(5):403-413. PubMed ID: 29322205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade.
    Hiraoka A; Kumada T; Nouso K; Tsuji K; Itobayashi E; Hirooka M; Kariyama K; Ishikawa T; Tada T; Toyoda H; Kawasaki H; Hiasa Y; Michitaka K
    Oncology; 2016; 91(3):153-61. PubMed ID: 27362669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
    Shao YY; Liu TH; Lee YH; Hsu CH; Cheng AL
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1336-41. PubMed ID: 26860846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
    Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
    Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
    World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
    J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
    Kim JH; Sinn DH; Lee JH; Hyun D; Cho SK; Shin SW; Chang Y; Kim YJ; Yoon JH; Kang W; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Choi MS
    Dig Dis Sci; 2018 Apr; 63(4):1062-1071. PubMed ID: 29442276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
    Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
    Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use.
    Kuo YH; Wang JH; Hung CH; Rau KM; Wu IP; Chen CH; Kee KM; Hu TH; Lu SN
    J Gastroenterol Hepatol; 2017 Dec; 32(12):1975-1981. PubMed ID: 28295594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
    Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ
    Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
    Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K;
    Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.